Immunotherapy is more effective when synchronized with dendritic cell functions, as the rhythmic transport of dendritic cells to the tumor-draining lymph node regulates the circadian response of tumor-antigen-specific CD8 T cells (46). The gene discussed is CD8A; the disease is neoplasm.